Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|January 1, 1985
Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-upJ M Raemaekers, L V Beex, A J Koenders, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Hypotensive effects of ovine and human corticotrophin-releasing factors in manA R Hermus, G F Pieters, J J Willemsen, et al.
Journal of Chromatography|November 17, 1993
Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin DH J van Hoof, L M Swinkels, J J van Stevenhagen, et al.
Acta Endocrinologica|March 1, 1990
Lack of antibody formation during long-term subcutaneous treatment with the somatostatin analogue octreotide in acromegalyP A van Liessum, L M Swinkels, G F Pieters, et al.
Endocrinology|November 1, 1992
Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the ratR M Hermus, C G Sweep, M J van der Meer, et al.
International Journal of Cancer|April 22, 1996
Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysisH H de Witte, J A Foekens, J Lennerstrand, et al.
Journal of Receptor Research|January 1, 1992
Scintillation proximity assay to study the interaction of epidermal growth factor with its receptorC B Kienhuis, A Geurts-Moespot, H A Ross, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1985
Aromatase inhibition by delta 1-testolactone does not relieve the gonadotropin-induced late steroidogenic block in normal menA G Smals, J M Dony, A E Smals, et al.
Journal of Steroid Biochemistry|December 1, 1987
Reciprocal inhibition of the long-acting luteinizing hormone releasing hormone agonist Buserelin and human chorionic gonadotropin in stimulating Leydig cell steroidogenesisA G Smals, G F Pieters, A E Smals, et al.
Cytokine|November 1, 1992
Chronic intraperitoneal infusion of low doses of tumor necrosis factor alpha in rats induces a reduction in plasma triglyceride levelsC G Sweep, R M Hermus, M J van der Meer, et al.
Pageof 13